Role of sulfur-containing gaseous substances in the cardiovascular system

Frontiers in Bioscience - Elite

Volumn 3 E, Issue 2, 2011, Pages 736-749

  Hart, Joanne L ^a  

^a RMIT UNIVERSITY   (Australia)

Author keywords

Endothelium; Gasotransmitter; Hydrogen Sulfide; Review; Sulfur Dioxide

Indexed keywords

3 MERCAPTOPYRUVATE SULFURTRANSFERASE; AMINOTRANSFERASE; ANTIHYPERTENSIVE AGENT; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; ASPARTATE AMINOTRANSFERASE; BETA SULFINYLPYRUVATE; CALCIMYCIN; CYSTATHIONINE BETA SYNTHASE; CYSTATHIONINE GAMMA LYASE; CYSTEINE; CYSTEINE AMINOTRANSFERASE; CYSTEINE DIOXYGENASE; CYSTEINE SULFINIC ACID; HOMOCYSTEINE; HYDROGEN SULFIDE; OXIDOREDUCTASE; PYRUVIC ACID DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SULFUR DIOXIDE; SULFURTRANSFERASE; THIOSULFATE; THIOSULFATE REDUCTASE; UNCLASSIFIED DRUG; VASODILATOR AGENT;

ANTIHYPERTENSIVE ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL TONE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; CARDIOVASCULAR SYSTEM; CHRONIC OBSTRUCTIVE LUNG DISEASE; ENDOTHELIUM CELL; HEART MITOCHONDRION; HUMAN; HYPERTENSION; INDUCED HYPOTHERMIA; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC HEART DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOPHYSIOLOGY; PULMONARY HYPERTENSION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE; VASODILATATION; CARDIOVASCULAR FUNCTION; ENDOTHELIUM; METABOLISM; PHYSIOLOGY; REVIEW;

CARDIOVASCULAR DISEASES; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; ENDOTHELIUM; HUMANS; HYDROGEN SULFIDE; SIGNAL TRANSDUCTION; SULFUR DIOXIDE;

EID: 79954621298     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: 10.2741/e282     Document Type: Article

References (156)

1. M. A. Gillman: Nitrous oxide as neurotransmitter. Lancet, 339(8788), 307 (1992)
2. M. Balazy, I. A. Abu-Yousef, D. N. Harpp and J. Park: Identification of carbonyl sulfide and sulfur dioxide in porcine coronary artery by gas chromatography/mass spectrometry, possible relevance to EDHF. Biochem Biophys Res Commun, 311(3), 728-34 (2003) (Pubitemid 37377717)
3. M. A. Gillman, L. Kok and F. J. Lichtigfeld: Paradoxical effect of naloxone on nitrous oxide analgesia in man. Eur J Pharmacol, 61(2), 175-7 (1980) (Pubitemid 10184317)
4. R. Acin-Perez, E. Salazar, M. Kamenetsky, J. Buck, L. R. Levin and G. Manfredi: Cyclic AMP produced inside mitochondria regulates oxidative phosphorylation. Cell Metab, 9(3), 265-76 (2009)
5. R. Wang: Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter? FASEB J, 16(13), 1792-8 (2002) (Pubitemid 35340360)
6. B. Locey: Hydrogen sulfide. In: Encyclopaedia of Toxicology. Elsevier Inc, (2005)
7. K. Abe and H. Kimura: The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci, 16(3), 1066-71 (1996) (Pubitemid 26140863)
8. R. Patacchini, P. Santicioli, S. Giuliani and C. A. Maggi: Hydrogen sulfide (H2S) stimulates capsaicin-sensitive primary afferent neurons in the rat urinary bladder. Br J Pharmacol, 142(1), 31-4 (2004) (Pubitemid 38698190)
9. E. Distrutti, L. Sediari, A. Mencarelli, B. Renga, S. Orlandi, E. Antonelli, F. Roviezzo, A. Morelli, G. Cirino, J. L. Wallace and S. Fiorucci: Evidence that hydrogen sulfide exerts antinociceptive effects in the gastrointestinal tract by activating KATP channels. J Pharmacol Exp Ther, 316(1), 325-35 (2006) (Pubitemid 41832612)
10. L. Wu, W. Yang, X. Jia, G. Yang, D. Duridanova, K. Cao and R. Wang: Pancreatic islet overproduction of H2S and suppressed insulin release in Zucker diabetic rats. Lab Invest, 89(1), 59-67 (2009)
11. X. Feng, Y. Chen, J. Zhao, C. Tang, Z. Jiang and B. Geng: Hydrogen sulfide from adipose tissue is a novel insulin resistance regulator. Biochem Biophys Res Commun, 380(1), 153-9 (2009)
12. S. Fiorucci, E. Antonelli, A. Mencarelli, S. Orlandi, B. Renga, G. Rizzo, E. Distrutti, V. Shah and A. Morelli: The third gas: H2S regulates perfusion pressure in both the isolated and perfused normal rat liver and in cirrhosis. Hepatology, 42(3), 539-48 (2005) (Pubitemid 41233646)
13. M. Xia, L. Chen, R. W. Muh, P. L. Li and N. Li: Production and actions of hydrogen sulfide, a novel gaseous bioactive substance, in the kidneys. J Pharmacol Exp Ther, 329(3), 1056-62 (2009)
14. B. Teague, S. Asiedu and P. K. Moore: The smooth muscle relaxant effect of hydrogen sulphide in vitro: evidence for a physiological role to control intestinal contractility. Br J Pharmacol, 137(2), 139-45 (2002)
15. D. J. Elsey, R. C. Fowkes and G. F. Baxter: Regulation of cardiovascular cell function by hydrogen sulfide (H2S). Cell Biochem Funct, 28(2), 95-106 (2010)
16. E. Blackstone, M. Morrison and M. B. Roth: H2S induces a suspended animation-like state in mice. Science, 308(5721), 518 (2005) (Pubitemid 40570576)
17. M. B. Roth and T. Nystul: Buying time in suspended animation. Sci Am, 292(6), 48-55 (2005) (Pubitemid 40844011)
18. J. W. Calvert, W. A. Coetzee and D. J. Lefer: Novel insights into hydrogen sulfide - mediated cytoprotection. Antioxid Redox Signal, 12(10), 1203-17
19. H. Zhang and M. Bhatia: Hydrogen sulfide: a novel mediator of leukocyte activation. Immunopharmacol Immunotoxicol, 30(4), 631-45 (2008)
20. J. C. Mathai, A. Missner, P. Kugler, S. M. Saparov, M. L. Zeidel, J. K. Lee and P. Pohl: No facilitator required for membrane transport of hydrogen sulfide. Proc Natl Acad Sci U S A, 106(39), 16633-8 (2009)
21. O. Kabil and R. Banerjee: The redox biochemistry of hydrogen sulfide. J Biol Chem (2010)
22. S. P. Alexander, A. Mathie and J. A. Peters: Guide to Receptors and Channels (GRAC), 3rd edition. Br J Pharmacol, 153 Suppl 2, S1-209 (2008)
23. K. Eto, M. Ogasawara, K. Umemura, Y. Nagai and H. Kimura: Hydrogen sulfide is produced in response to neuronal excitation. J Neurosci, 22(9), 3386-91 (2002) (Pubitemid 37465744)
24. I. Ishii, N. Akahoshi, X. N. Yu, Y. Kobayashi, K. Namekata, G. Komaki and H. Kimura: Murine cystathionine gamma-lyase: complete cDNA and genomic sequences, promoter activity, tissue distribution and developmental expression. Biochem J, 381(Pt 1), 113-23 (2004) (Pubitemid 38932217)
25. L. Diwakar and V. Ravindranath: Inhibition of cystathionine-gamma-lyase leads to loss of glutathione and aggravation of mitochondrial dysfunction mediated by excitatory amino acid in the CNS. Neurochem Int, 50(2), 418-26 (2007) (Pubitemid 46110921)
26. V. Vitvitsky, M. Thomas, A. Ghorpade, H. E. Gendelman and R. Banerjee: A functional transsulfuration pathway in the brain links to glutathione homeostasis. J Biol Chem, 281(47), 35785-93 (2006) (Pubitemid 46041310)
27. O. W. Griffith: Mammalian sulfur amino acid metabolism: an overview. Methods Enzymol, 143, 366-76 (1987)
28. N. Shibuya, M. Tanaka, M. Yoshida, Y. Ogasawara, T. Togawa, K. Ishii and H. Kimura: 3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain. Antioxid Redox Signal, 11(4), 703-14 (2009)
29. N. Shibuya, Y. Mikami, Y. Kimura, N. Nagahara and H. Kimura: Vascular endothelium expresses 3- mercaptopyruvate sulfurtransferase and produces hydrogen sulfide. J Biochem, 146(5), 623-6 (2009)
30. J. Furne, J. Springfield, T. Koenig, E. DeMaster and M. D. Levitt: Oxidation of hydrogen sulfide and methanethiol to thiosulfate by rat tissues: a specialized function of the colonic mucosa. Biochem Pharmacol, 62(2), 255-9 (2001) (Pubitemid 32522947)
31. D. Searcy and S. Lee: Sulfur reduction by human erythrocytes. Journal of Experimental Zoology, 282, 310-322 (1998) (Pubitemid 28448296)
32. M. Ishigami, K. Hiraki, K. Umemura, Y. Ogasawara, K. Ishii and H. Kimura: A source of hydrogen sulfide and a mechanism of its release in the brain. Antioxid Redox Signal, 11(2), 205-14 (2009)
33. R. O. Beauchamp, Jr., J. S. Bus, J. A. Popp, C. J. Boreiko and D. A. Andjelkovich: A critical review of the literature on hydrogen sulfide toxicity. Crit Rev Toxicol, 13(1), 25-97 (1984) (Pubitemid 14069476)
34. K. R. Olson and J. A. Donald: Nervous control of circulation - the role of gasotransmitters, NO, CO, and H2S. Acta Histochem, 111(3), 244-56 (2009)
35. J. Furne, A. Saeed and M. D. Levitt: Whole tissue hydrogen sulfide concentrations are orders of magnitude lower than presently accepted values. Am J Physiol Regul Integr Comp Physiol, 295(5), R1479-85 (2008)
36. G. Tang, L. Wu, W. Liang and R. Wang: Direct stimulation of K(ATP) channels by exogenous and endogenous hydrogen sulfide in vascular smooth muscle cells. Mol Pharmacol, 68(6), 1757-64 (2005) (Pubitemid 41654358)
37. A. K. Mustafa, M. M. Gadalla, N. Sen, S. Kim, W. Mu, S. K. Gazi, R. K. Barrow, G. Yang, R. Wang and S. H. Snyder: H2S signals through protein S-sulfhydration. Sci Signal, 2(96), ra72 (2009)
38. B. Jiang, G. Tang, K. Cao, L. Wu and R. Wang: Molecular mechanism for H(2)S-induced activation of K(ATP) channels. Antioxid Redox Signal, 12(10), 1167-78 (2010)
39. W. Zhao, J. Zhang, Y. Lu and R. Wang: The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. EMBO J, 20(21), 6008-16 (2001) (Pubitemid 33049276)
40. Y. Cheng, J. Ndisang, G. Tang, K. Cao and R. Wang: Hydrogen sulfide-induced relaxation of resistance mesenteric artery beds of rats. Am J Physiol Heart Circ Physiol, 287, 2316-2323 (2004)
41. V. Telezhkin, S. P. Brazier, S. Cayzac, C. T. Muller, D. Riccardi and P. J. Kemp: Hydrogen sulfide inhibits human BK(Ca) channels. Adv Exp Med Biol, 648, 65-72 (2009)
42. W. S. Cheang, W. T. Wong, B. Shen, C. W. Lau, X. Y. Tian, S. Y. Tsang, X. Yao, Z. Y. Chen and Y. Huang: 4- Aminopyridine-sensitive K+ channels contributes to NaHSinduced membrane hyperpolarization and relaxation in the rat coronary artery. Vascul Pharmacol (2010)
43. Y. G. Sun, Y. X. Cao, W. W. Wang, S. F. Ma, T. Yao and Y. C. Zhu: Hydrogen sulphide is an inhibitor of L-type calcium channels and mechanical contraction in rat cardiomyocytes. Cardiovasc Res, 79(4), 632-41 (2008)
44. W. Zhao and R. Wang: H(2)S-induced vasorelaxation and underlying cellular and molecular mechanisms. Am J Physiol Heart Circ Physiol, 283(2), H474-80 (2002) (Pubitemid 34790838)
45. C. C. Bauer, J. P. Boyle, K. E. Porter and C. Peers: Modulation of Ca(2+) signaling in human vascular endothelial cells by hydrogen sulfide. Atherosclerosis, 209(2), 374-80 (2010)
46. S. W. Lee, Y. Cheng, P. K. Moore and J. S. Bian: Hydrogen sulphide regulates intracellular pH in vascular smooth muscle cells. Biochem Biophys Res Commun, 358(4), 1142-7 (2007) (Pubitemid 46829008)
47. L. Kiss, E. A. Deitch and C. Szabo: Hydrogen sulfide decreases adenosine triphosphate levels in aortic rings and leads to vasorelaxation via metabolic inhibition. Life Sci, 83(17-18), 589-94 (2008)
48. H. Yan, J. Du and C. Tang: The possible role of hydrogen sulfide on the pathogenesis of spontaneous hypertension in rats. Biochem Biophys Res Commun, 313(1), 22-7 (2004) (Pubitemid 37524019)
49. G. Yang, L. Wu, B. Jiang, W. Yang, J. Qi, K. Cao, Q. Meng, A. K. Mustafa, W. Mu, S. Zhang, S. H. Snyder and R. Wang: H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science, 322(5901), 587-90 (2008)
50. M. Lu, Y. H. Liu, H. S. Goh, J. J. Wang, Q. C. Yong, R. Wang and J. S. Bian: Hydrogen sulfide inhibits plasma Renin activity. J Am Soc Nephrol, 21(6), 993-1002 (2010)
51. H. Laggner, M. Hermann, H. Esterbauer, M. K. Muellner, M. Exner, B. M. Gmeiner and S. Kapiotis: The novel gaseous vasorelaxant hydrogen sulfide inhibits angiotensin-converting enzyme activity of endothelial cells. J Hypertens, 25(10), 2100-4 (2007) (Pubitemid 47476307)
52. W. Zhao, J. Ndisang and R. Wang: Modulation of endogenous production of H2S in rat tissues. Can J Physiol Pharmacol, 81(9), 848-853 (2003) (Pubitemid 37188260)
53. G. Zhong, F. Chen, Y. Cheng, C. Tang and J. Du: The role of hydrogen sulphide generation in the pathogenesis of hypertension in rats induced by inhibition of nitric oxide synthase Journal of Hypertension 21(10), 1879-85 (2003) (Pubitemid 37290106)
54. B. Geng, Y. Cui, J. Zhao, F. Yu, Y. Zhu, G. Xu, Z. Zhang, C. Tang and J. Du: Hydrogen sulfide downregulates the aortic L-arginine/nitric oxide pathway in rats. Am J Physiol Regul Integr Comp Physiol, 293(4), R1608-18 (2007) (Pubitemid 47535779)
55. S. Kubo, I. Doe, Y. Kurokawa, H. Nishikawa and A. Kawabata: Direct inhibition of endothelial nitric oxide synthase by hydrogen sulfide: contribution to dual modulation of vascular tension. Toxicology, 232(1-2), 138-46 (2007) (Pubitemid 46283181)
56. M. Whiteman, L. Li, I. Kostetski, S. H. Chu, J. L. Siau, M. Bhatia and P. K. Moore: Evidence for the formation of a novel nitrosothiol from the gaseous mediators nitric oxide and hydrogen sulphide. Biochem Biophys Res Commun, 343(1), 303-10 (2006)
57. M. Whiteman, J. Armstong, S. Chu, S. Jia-Ling, B. Wong, N. Cheung, B. Halliwell and P. Moore: The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite 'scavenger'? J Neurochem, 90, 765-768 (2004) (Pubitemid 38989409)
58. C. C. Dahm, K. Moore and M. P. Murphy: Persistent Snitrosation of complex I and other mitochondrial membrane proteins by S-nitrosothiols but not nitric oxide or peroxynitrite: implications for the interaction of nitric oxide with mitochondria. J Biol Chem, 281(15), 10056-65 (2006) (Pubitemid 43864540)
59. B. Geng, L. Chang, C. Pan, Y. Qi, J. Zhao, Y. Pang, J. Du and C. Tang: Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol. Biochemical and Biophysical Research Communications, 318, 756-763 (2004) (Pubitemid 38624219)
60. L. Chang, B. Geng, F. Yu, J. Zhao, H. Jiang, J. Du and C. Tang: Hydrogen sulfide inhibits myocardial injury induced by homocysteine in rats. Amino Acids, 34(4), 573-85 (2008)
61. M. Whiteman, P. Rose, J. L. Siau, N. S. Cheung, G. S. Tan, B. Halliwell and J. S. Armstrong: Hypochlorous acidmediated mitochondrial dysfunction and apoptosis in human hepatoma HepG2 and human fetal liver cells: role of mitochondrial permeability transition. Free Radic Biol Med, 38(12), 1571-84 (2005) (Pubitemid 40726064)
62. H. Laggner, M. K. Muellner, S. Schreier, B. Sturm, M. Hermann, M. Exner, B. M. Gmeiner and S. Kapiotis: Hydrogen sulphide: a novel physiological inhibitor of LDL atherogenic modification by HOCl. Free Radic Res, 41(7), 741-7 (2007) (Pubitemid 46995255)
63. M. Y. Ali, C. Y. Ping, Y. Y. Mok, L. Ling, M. Whiteman, M. Bhatia and P. K. Moore: Regulation of vascular nitric oxide in vitro and in vivo; a new role for endogenous hydrogen sulphide? Br J Pharmacol, 149(6), 625-34 (2006) (Pubitemid 44748055)
64. A. Stasko, V. Brezova, M. Zalibera, S. Biskupic and K. Ondrias: Electron transfer: a primary step in the reactions of sodium hydrosulphide, an H2S/HS(-) donor. Free Radic Res, 43(6), 581-93 (2009)
65. S. Muzaffar, N. Shukla, M. Bond, A. C. Newby, G. D. Angelini, A. Sparatore, P. Del Soldato and J. Y. Jeremy: Exogenous hydrogen sulfide inhibits superoxide formation, NOX-1 expression and Rac1 activity in human vascular smooth muscle cells. J Vasc Res, 45(6), 521-8 (2008)
66. A. K. Samhan-Arias, M. A. Garcia-Bereguiain and C. Gutierrez-Merino: Hydrogen sulfide is a reversible inhibitor of the NADH oxidase activity of synaptic plasma membranes. Biochem Biophys Res Commun, 388(4), 718-22 (2009)
67. H. Kimura: Hydrogen sulfide as a neuromodulator. Mol Neurobiol, 26(1), 13-9 (2002) (Pubitemid 35176864)
68. Y. Kimura and H. Kimura: Hydrogen sulfide protects neurons from oxidative stress. FASEB J. , 18(10), 1165-7 (2004) (Pubitemid 39561558)
69. Y. Kimura, R. Dargusch, D. Schubert and H. Kimura: Hydrogen sulfide protects HT22 neuronal cells from oxidative stress. Antioxid Redox Signal, 8(3-4), 661-70 (2006) (Pubitemid 43741334)
70. H. L. Wei, C. Y. Zhang, H. F. Jin, C. S. Tang and J. B. Du: Hydrogen sulfide regulates lung tissue-oxidized glutathione and total antioxidant capacity in hypoxic pulmonary hypertensive rats. Acta Pharmacol Sin, 29(6), 670-9 (2008)
71. G. D. Webb, L. H. Lim, V. M. Oh, S. B. Yeo, Y. P. Cheong, M. Y. Ali, R. El Oakley, C. N. Lee, P. S. Wong, M. G. Caleb, M. Salto-Tellez, M. Bhatia, E. S. Chan, E. A. Taylor and P. K. Moore: Contractile and vasorelaxant effects of hydrogen sulfide and its biosynthesis in the human internal mammary artery. J Pharmacol Exp Ther, 324(2), 876-82 (2008) (Pubitemid 351185840)
72. R. Wang: Hydrogen sulfide: a new EDRF. Kidney Int, 76(7), 700-4 (2009)
73. V. Brancaleone, F. Roviezzo, V. Vellecco, L. De Gruttola, M. Bucci and G. Cirino: Biosynthesis of H2S is impaired in non-obese diabetic (NOD) mice. Br J Pharmacol, 155(5), 673-80 (2008)
74. Y. Chen, W. Yao, B. Geng, Y. Ding, M. Lu, M. Zhao and C. Tang: Endogenous hydrogen sulfide in patients with COPD. Chest, 128(5), 3205-3211 (2005) (Pubitemid 41699831)
75. H. Jiang, H. Wu, Z. Li, B. Geng and C. Tang: Changes of the new gaseous transmitter H2S in patients with coronary heart disease. Di Yi Junyi Daxue Xuebao, 25(8), 951-4 (2005)
76. L. Chen, S. Ingrid, Y. G. Ding, Y. Liu, J. G. Qi, C. S. Tang and J. B. Du: Imbalance of endogenous homocysteine and hydrogen sulfide metabolic pathway in essential hypertensive children. Chin Med J (Engl), 120(5), 389-93 (2007) (Pubitemid 46488350)
77. W. Yanfei, S. Lin, D. Junbao and T. Chaoshu: Impact of L-arginine on hydrogen sulfide/cystathionine-gammalyase pathway in rats with high blood flow-induced pulmonary hypertension. Biochem Biophys Res Commun, 345(2), 851-7 (2006) (Pubitemid 43776965)
78. M. Yusuf, B. Huat, A. Hsu, M. Whiteman, M. Bhatia and P. Moore: Streptozotocin-induced diabetes in the rat is associated with enhanced tissue hydrogen sulfide biosynthesis. Biochem Biophys Res Commun, 333, 1146-1152 (2005) (Pubitemid 40910123)
79. S. K. Jain, R. Bull, J. L. Rains, P. F. Bass, S. N. Levine, S. Reddy, R. McVie and J. A. Bocchini: Low levels of hydrogen sulfide in the blood of diabetes patients and streptozotocin-treated rats causes vascular inflammation? Antioxid Redox Signal, 12(11), 1333-7 (2010)
80. M. Whiteman, K. M. Gooding, J. L. Whatmore, C. I. Ball, D. Mawson, K. Skinner, J. E. Tooke and A. C. Shore: Adiposity is a major determinant of plasma levels of the novel vasodilator hydrogen sulphide. Diabetologia
81. J. W. Calvert, S. Jha, S. Gundewar, J. W. Elrod, A. Ramachandran, C. B. Pattillo, C. G. Kevil and D. J. Lefer: Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Circ Res, 105(4), 365-74 (2009)
82. Z. Zhang, H. Huang, P. Liu, C. Tang and J. Wang: Hydrogen sulfide contributes to cardioprotection during ischemia-reperfusion injury by opening K ATP channels. Can J Physiol Pharmacol, 85(12), 1248-53 (2007) (Pubitemid 351196401)
83. M. Bliksoen, M. L. Kaljusto, J. Vaage and K. O. Stenslokken: Effects of hydrogen sulphide on ischaemiareperfusion injury and ischaemic preconditioning in the isolated, perfused rat heart. Eur J Cardiothorac Surg, 34(2), 344-9 (2008)
84. X. Y. Zhu, X. H. Yan and S. J. Chen: H2S protects myocardium against ischemia/reperfusion injury and its effect on c-Fos protein expression in rats. Sheng Li Xue Bao, 60(2), 221-7 (2008)
85. J. W. Elrod, J. W. Calvert, J. Morrison, J. E. Doeller, D. W. Kraus, L. Tao, X. Jiao, R. Scalia, L. Kiss, C. Szabo, H. Kimura, C. W. Chow and D. J. Lefer: Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci U S A, 104(39), 15560-5 (2007) (Pubitemid 47502956)
86. Y. Hu, X. Chen, T. T. Pan, K. L. Neo, S. W. Lee, E. S. Khin, P. K. Moore and J. S. Bian: Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways. Pflugers Arch, 455(4), 607-16 (2008) (Pubitemid 350160475)
87. N. R. Sodha, R. T. Clements, J. Feng, Y. Liu, C. Bianchi, E. M. Horvath, C. Szabo, G. L. Stahl and F. W. Sellke: Hydrogen sulfide therapy attenuates the inflammatory response in a porcine model of myocardial ischemia/reperfusion injury. J Thorac Cardiovasc Surg, 138(4), 977-84 (2009)
88. A. Sivarajah, M. C. McDonald and C. Thiemermann: The production of hydrogen sulphide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of precoditioning with endotoxin, but not ischemia in rats. Shock, 26, 154-161 (2006) (Pubitemid 44162501)
89. D. Johansen, K. Ytrehus and G. Baxter: Exogenous hydrogen sulfide (H2S) protects against regional myocardial ischemia-reperfusion injury - Evidence for a role for KATP channels. Basic Res Cardiol, 101(1), 53-60 (2006) (Pubitemid 43323432)
90. D. J. Elsey, R. C. Fowkes and G. F. Baxter: L-cysteine stimulates hydrogen sulfide synthesis in myocardium associated with attenuation of ischemia-reperfusion injury. J Cardiovasc Pharmacol Ther, 15(1), 53-9
91. J. S. Bian, Q. C. Yong, T. T. Pan, Z. N. Feng, M. Y. Ali, S. Zhou and P. K. Moore: Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes. J Pharmacol Exp Ther, 316(2), 670-8 (2006) (Pubitemid 43130994)
92. G. Zagli, R. Patacchini, M. Trevisani, R. Abbate, S. Cinotti, G. F. Gensini, G. Masotti and P. Geppetti: Hydrogen sulfide inhibits human platelet aggregation. Eur J Pharmacol, 559(1), 65-8 (2007) (Pubitemid 46274652)
93. A. Sivarajah, M. Collino, M. Yasin, E. Benetti, M. Gallicchio, E. Mazzon, S. Cuzzocrea, R. Fantozzi and C. Thiemermann: Anti-apoptotic and anti-inflammatory effects of hydrogen sulfide in a rat model of regional myocardial I/R. Shock, 31(3), 267-74 (2009)
94. G. Rossoni, A. Sparatore, V. Tazzari, B. Manfredi, P. Del Soldato and F. Berti: The hydrogen sulphide-releasing derivative of diclofenac protects against ischaemiareperfusion injury in the isolated rabbit heart. Brit J Pharmacol, 153, 100-109 (2008)
95. L. L. Yao, X. W. Huang, Y. G. Wang, Y. X. Cao, C. C. Zhang and Y. C. Zhu: Hydrogen sulfide protects cardiomyocytes from hypoxia/reoxygenation-induced apoptosis by preventing GSK-3beta-dependent opening of mPTP. Am J Physiol Heart Circ Physiol, 298(5), H1310-9 (2010)
96. S. Shi, Q. S. Li, H. Li, L. Zhang, M. Xu, J. L. Cheng, C. H. Peng, C. Q. Xu and Y. Tian: Anti-apoptotic action of hydrogen sulfide is associated with early JNK inhibition. Cell Biol Int, 33(10), 1095-101 (2009)
97. N. R. Sodha, R. T. Clements, J. Feng, Y. Liu, C. Bianchi, E. M. Horvath, C. Szabo and F. W. Sellke: The effects of therapeutic sulfide on myocardial apoptosis in response to ischemia-reperfusion injury. Eur J Cardiothorac Surg, 33(5), 906-13 (2008)
98. T. Pan, K. Neo, L. Hu, Q. Yong and J. Bian: H2S preconditioning-induced PKC activation regulates intracellular calcium handling in rat cardiomyocytes. American Journal of Physiology - Cell Physiology, 294(1), C169-77 (2008)
99. Q. C. Yong, S. W. Lee, C. S. Foo, K. L. Neo, X. Chen and J. S. Bian: Endogenous hydrogen sulphide mediates the cardioprotection induced by ischemic postconditioning. Am J Physiol Heart Circ Physiol, 295(3), H1330-H1340 (2008)
100. Y. Ji, Q. F. Pang, G. Xu, L. Wang, J. K. Wang and Y. M. Zeng: Exogenous hydrogen sulfide postconditioning protects isolated rat hearts against ischemia-reperfusion injury. Eur J Pharmacol, 587(1-3), 1-7 (2008)
101. J. Du, Y. Hui, Y. Cheung, G. Bin, H. Jiang, X. Chen and C. Tang: The possible role of hydrogen sulfide as a smooth muscle cell proliferation inhibitor in rat cultured cells. Heart Vessels, 19(2), 75-80 (2004) (Pubitemid 38489034)
102. R. Baskar, A. Sparatore, P. Del Soldato and P. K. Moore: Effect of S-diclofenac, a novel hydrogen sulfide releasing derivative inhibit rat vascular smooth muscle cell proliferation. Eur J Pharmacol, 594(1-3), 1-8 (2008)
103. G. Yang, K. Cao, L. Wu and R. Wang: Cystathionine gamma-lyase overexpression inhibits cell proliferation via a H2S-dependent modulation of ERK1/2 phosphorylation and p21Cip/WAK-1. J Biol Chem, 279(47), 49199-205 (2004) (Pubitemid 39625803)
104. G. Yang, L. Wu and R. Wang: Pro-apoptotic effect of endogenous H2S on human aorta smooth muscle cells. FASEB J, 20(3), 553-5 (2006) (Pubitemid 46671247)
105. Q. H. Meng, G. Yang, W. Yang, B. Jiang, L. Wu and R. Wang: Protective effect of hydrogen sulfide on balloon injury-induced neointima hyperplasia in rat carotid arteries. Am J Pathol, 170(4), 1406-14 (2007) (Pubitemid 47339347)
106. X. Zhao, L. K. Zhang, C. Y. Zhang, X. J. Zeng, H. Yan, H. F. Jin, C. S. Tang and J. B. Du: Regulatory effect of hydrogen sulfide on vascular collagen content in spontaneously hypertensive rats. Hypertens Res, 31(8), 1619-30 (2008)
107. W. J. Cai, M. J. Wang, P. K. Moore, H. M. Jin, T. Yao and Y. C. Zhu: The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation. Cardiovasc Res, 76(1), 29-40 (2007) (Pubitemid 47362041)
108. R. Wang: Is H2S a stinky remedy for atherosclerosis? Arterioscler Thromb Vasc Biol, 29(2), 156-7 (2009)
109. W. Qiao, T. Chaoshu, J. Hongfang and D. Junbao: Endogenous hydrogen sulfide is involved in the pathogenesis of atherosclerosis. Biochem Biophys Res Commun, 396(2), 182-186 (2010)
110. R. Clarke: Homocysteine and cardiovascular disease. Overview. J Cardiovasc Risk, 5(4), 213-5 (1998)
111. S. K. Yan, T. Chang, H. Wang, L. Wu, R. Wang and Q. H. Meng: Effects of hydrogen sulfide on homocysteineinduced oxidative stress in vascular smooth muscle cells. Biochem Biophys Res Commun, 351(2), 485-91 (2006) (Pubitemid 44755144)
112. C. P. Judkins, H. Diep, B. R. Broughton, A. E. Mast, E. U. Hooker, A. A. Miller, S. Selemidis, G. J. Dusting, C. G. Sobey and G. R. Drummond: Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE-/- mice. Am J Physiol Heart Circ Physiol, 298(1), H24-32
113. S. Muzaffar, J. Y. Jeremy, A. Sparatore, P. Del Soldato, G. D. Angelini and N. Shukla: H2S-donating sildenafil (ACS6) inhibits superoxide formation and gp91phox expression in arterial endothelial cells: role of protein kinases A and G. Br J Pharmacol, 155(7), 984-94 (2008)
114. S. Selemidis, C. G. Sobey, K. Wingler, H. H. Schmidt and G. R. Drummond: NADPH oxidases in the vasculature: molecular features, roles in disease and pharmacological inhibition. Pharmacol Ther, 120(3), 254-91 (2008)
115. S. Y. Wu, C. S. Pan, B. Geng, J. Zhao, F. Yu, Y. Z. Pang, C. S. Tang and Y. F. Qi: Hydrogen sulfide ameliorates vascular calcification induced by vitamin D3 plus nicotine in rats. Acta Pharmacol Sin, 27(3), 299-306 (2006) (Pubitemid 43357025)
116. Y. Wang, X. Zhao, H. Jin, H. Wei, W. Li, D. Bu, X. Tang, Y. Ren, C. Tang and J. Du: Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol, 29(2), 173-9 (2009)
117. R. C. Zanardo, V. Brancaleone, E. Distrutti, S. Fiorucci, G. Cirino and J. L. Wallace: Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J, 20(12), 2118-20 (2006)
118. W. Yang, G. Yang, J. X, L. Wu and R. Wang: Activation of KATP channels by H2S in rat insulin-secreting cells and the underlying mechanisms. J Physiol, 569(2), 519-531 (2005) (Pubitemid 41830119)
119. M. Y. Ali, M. Whiteman, C. M. Low and P. K. Moore: Hydrogen sulphide reduces insulin secretion from HIT-T15 cells by a KATP channel-dependent pathway. J Endocrinol, 195(1), 105-12 (2007) (Pubitemid 350056004)
120. G. D. Yang and R. Wang: H2S and cellular proliferation and apoptosis. Sheng Li Xue Bao, 59(2), 133-40 (2007)
121. S. Fiorucci, L. Santucci and E. Distrutti: NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: what lies beyond the horizon. Dig Liver Dis, 39(12), 1043-51 (2007) (Pubitemid 350131544)
122. K. Baumgart, F. Wagner, M. Groger, S. Weber, E. Barth, J. A. Vogt, U. Wachter, M. Huber-Lang, M. W. Knoferl, G. Albuszies, M. Georgieff, P. Asfar, C. Szabo, E. Calzia, P. Radermacher and V. Simkova: Cardiac and metabolic effects of hypothermia and inhaled hydrogen sulfide in anesthetized and ventilated mice. Crit Care Med, 38(2), 588-95 (2010)
123. M. O. Amdur: Toxicologic appraisal of particulate matter, oxides of sulfur, and sulfuric acid. J Air Pollut Control Assoc, 19(9), 638-44 (1969)
124. V. Lenters, C. S. Uiterwaal, R. Beelen, M. L. Bots, P. Fischer, B. Brunekreef and G. Hoek: Long-Term Exposure to Air Pollution and Vascular Damage in Young Adults. Epidemiology (2010)
125. H. Kan, C. M. Wong, N. Vichit-Vadakan and Z. Qian: Short-term association between sulfur dioxide and daily mortality: the Public Health and Air Pollution in Asia (PAPA) study. Environ Res, 110(3), 258-64
126. K. Bhaskaran, S. Hajat, A. Haines, E. Herrett, P. Wilkinson and L. Smeeth: Effects of air pollution on the incidence of myocardial infarction. Heart, 95(21), 1746-59 (2009)
127. M. Briet, C. Collin, S. Laurent, A. Tan, M. Azizi, M. Agharazii, X. Jeunemaitre, F. Alhenc-Gelas and P. Boutouyrie: Endothelial function and chronic exposure to air pollution in normal male subjects. Hypertension, 50(5), 970-6 (2007) (Pubitemid 350287543)
128. A. Bener, M. Dogan and N. J. Shanks: The impact of air pollution on hospital admission for respiratory and cardiovascular diseases in an oil-rich country. East Afr J Public Health, 6(2), 124-7 (2009)
129. A. F. Gunnison and A. W. Benton: Sulfur dioxide: Sulfite. Interaction with mammalian serum and plasma. Arch Environ Health, 22(3), 381-8 (1971)
130. J. Xie, R. Fan and Z. Meng: Protein oxidation and DNAprotein crosslink induced by sulfur dioxide in lungs, livers, and hearts from mice. Inhal Toxicol, 19(9), 759-65 (2007) (Pubitemid 47026978)
131. M. H. Stipanuk, J. E. Dominy, Jr., J. I. Lee and R. M. Coloso: Mammalian cysteine metabolism: new insights into regulation of cysteine metabolism. J Nutr, 136(6 Suppl), 1652S-1659S (2006) (Pubitemid 43765376)
132. R. Shapiro: Genetic effects of bisulfite (sulfur dioxide). Mutat Res, 39(2), 149-75 (1977) (Pubitemid 8047072)
133. H. Mitsuhashi, S. Yamashita, H. Ikeuchi, T. Kuroiwa, Y. Kaneko, K. Hiromura, K. Ueki and Y. Nojima: Oxidative stress-dependent conversion of hydrogen sulfide to sulfite by activated neutrophils. Shock, 24(6), 529-34 (2005)
134. T. Ubuka, S. Yuasa, J. Ohta, N. Masuoka, K. Yao and M. Kinuta: Formation of sulfate from L-cysteine in rat liver mitochondria. Acta Med Okayama, 44(2), 55-64 (1990) (Pubitemid 20328841)
135. O. W. Griffith: Cysteinesulfinate metabolism. altered partitioning between transamination and decarboxylation following administration of beta-methyleneaspartate. J Biol Chem, 258(3), 1591-8 (1983) (Pubitemid 13101366)
136. M. H. Stipanuk and J. E. Dominy, Jr.: Surprising insights that aren't so surprising in the modeling of sulfur amino acid metabolism. Amino Acids, 30(3), 251-6 (2006) (Pubitemid 43724052)
137. S. X. Du, H. F. Jin, D. F. Bu, X. Zhao, B. Geng, C. S. Tang and J. B. Du: Endogenously generated sulfur dioxide and its vasorelaxant effect in rats. Acta Pharmacol Sin, 29(8), 923-30 (2008)
138. H. F. Jin, S. X. Du, X. Zhao, S. Q. Zhang, Y. Tian, D. F. Bu, C. S. Tang and J. B. Du: Significance of endogenous sulfur dioxide in the regulation of cardiovascular system. Beijing Da Xue Xue Bao, 39(4), 423-5 (2007)
139. Z. Meng and H. Zhang: The vasodilator effect and its mechanism of sulfur dioxide-derivatives on isolated aortic rings of rats. Inhal Toxicol, 19(11), 979-86 (2007) (Pubitemid 350112223)
140. Y. Sun, Y. Tian, M. Prabha, D. Liu, S. Chen, R. Zhang, X. Liu, C. Tang, X. Tang, H. Jin and J. Du: Effects of sulfur dioxide on hypoxic pulmonary vascular structural remodeling. Lab Invest, 90(1), 68-82 (2010)
141. S. X. Du, J. B. Du and C. S. Tang: Advances in study of physiologic effects of endogenous sulfur dioxide and its derivatives. Beijing Da Xue Xue Bao, 38(3), 331-4 (2006)
142. Z. Meng, Y. Li and J. Li: Vasodilatation of sulfur dioxide derivatives and signal transduction. Arch Biochem Biophys, 467(2), 291-6 (2007) (Pubitemid 350050898)
143. J. Li and Z. Meng: The role of sulfur dioxide as an endogenous gaseous vasoactive factor in synergy with nitric oxide. Nitric Oxide, 20(3), 166-74 (2009)
144. Q. Zhang and Z. Meng: The vasodilator mechanism of sulfur dioxide on isolated aortic rings of rats: Involvement of the K+ and Ca2+ channels. Eur J Pharmacol, 602(1), 117-23 (2009)
145. Y. K. Wang, A. J. Ren, X. Q. Yang, L. G. Wang, W. F. Rong, C. S. Tang, W. J. Yuan and L. Lin: Sulfur dioxide relaxes rat aorta by endothelium-dependent and - independent mechanisms. Physiol Res, 58(4), 521-7 (2009)
146. Z. Meng, H. Geng, J. Bai and G. Yan: Blood pressure of rats lowered by sulfur dioxide and its derivatives. Inhal Toxicol, 15(9), 951-9 (2003) (Pubitemid 37051731)
147. S. Q. Zhang, J. B. Du, Y. Tian, B. Geng, C. S. Tang and X. Y. Tang: [Effects of sulfur dioxide on cardiac function of isolated perfusion heart of rat]. Zhonghua Yi Xue Za Zhi, 88(12), 830-4 (2008) (Pubitemid 351756804)
148. A. Nie and Z. Meng: Modulation of L-type calcium current in rat cardiac myocytes by sulfur dioxide derivatives. Food Chem Toxicol, 44(3), 355-63 (2006) (Pubitemid 41779435)
149. A. Nie and Z. Meng: Sulfur dioxide derivatives modulate Na/Ca exchange currents and cytosolic [Ca2+]i in rat myocytes. Biochem Biophys Res Commun, 358(3), 879-84 (2007) (Pubitemid 46813131)
150. A. Nie and Z. Meng: Study of the interaction of sulfur dioxide derivative with cardiac sodium channel. Biochim Biophys Acta, 1718(1-2), 67-73 (2005) (Pubitemid 41698897)
151. A. Nie and Z. Meng: Sulfur dioxide derivative modulation of potassium channels in rat ventricular myocytes. Arch Biochem Biophys, 442(2), 187-95 (2005) (Pubitemid 41463709)
152. S. Zhang, J. Du, H. Jin, W. Li, Y. Liang, B. Geng, S. Li, C. Zhang and C. Tang: Endogenous sulfur dioxide aggravates myocardial injury in isolated rat heart with ischemia and reperfusion. Transplantation, 87(4), 517-24 (2009)
153. Z. Meng: Oxidative damage of sulfur dioxide on various organs of mice: sulfur dioxide is a systemic oxidative damage agent. Inhal Toxicol, 15(2), 181-95 (2003) (Pubitemid 36222338)
154. J. Bai and Z. Meng: Expression of caspase and apoptotic signal pathway induced by sulfur dioxide. Environ Mol Mutagen, 51(2), 112-22
155. J. Bai and Z. Meng: Effects of sulfur dioxide on apoptosis-related gene expressions in lungs from rats. Regul Toxicol Pharmacol, 43(3), 272-9 (2005) (Pubitemid 41616393)
156. J. Bai and Z. Meng: Expression of apoptosis-related genes in livers from rats exposed to sulfur dioxide. Toxicology, 216(2-3), 253-60 (2005) (Pubitemid 41712014)